Michael E Gertner - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Michael E Gertner

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Current Treatment Options in Oncology|July 6, 2004

Multiple endocrine neoplasia type 2Michael E Gertner, Electron Kebebew

Ophthalmology|September 12, 2014

Stereotactic radiotherapy for neovascular age-related macular degeneration: year 2 results of the INTREPID studyTimothy L Jackson, Usha Chakravarthy, Jason S Slakter, et al.

Ophthalmology|March 16, 2013

Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID studyTimothy L Jackson, Usha Chakravarthy, Peter K Kaiser, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Current Treatment Options in Oncology|July 6, 2004

Multiple endocrine neoplasia type 2Michael E Gertner, Electron Kebebew

Ophthalmology|September 12, 2014

Stereotactic radiotherapy for neovascular age-related macular degeneration: year 2 results of the INTREPID studyTimothy L Jackson, Usha Chakravarthy, Jason S Slakter, et al.

Ophthalmology|March 16, 2013

Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID studyTimothy L Jackson, Usha Chakravarthy, Peter K Kaiser, et al.

Pageof 1